Luqmani RA - Search Results

1

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis.

Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, Craven A, Khalid S, Hutchings A, Watts RA, Merkel PA, Luqmani RA; DCVAS Study Group. Ponte C, et al. Among authors: luqmani ra. Ann Rheum Dis. 2022 Dec;81(12):1647-1653. doi: 10.1136/ard-2022-223480. Epub 2022 Nov 9. Ann Rheum Dis. 2022. PMID: 36351706

2

A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.

Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, Cohen P, Calabrese LH, Dickler H, Merkel PA, Fortin P, Flynn JA, Locker GA, Easley KA, Schned E, Hunder GG, Sneller MC, Tuggle C, Swanson H, Hernández-Rodríguez J, Lopez-Soto A, Bork D, Hoffman DB, Kalunian K, Klashman D, Wilke WS, Scheetz RJ, Mandell BF, Fessler BJ, Kosmorsky G, Prayson R, Luqmani RA, Nuki G, McRorie E, Sherrer Y, Baca S, Walsh B, Ferland D, Soubrier M, Choi HK, Gross W, Segal AM, Ludivico C, Puechal X; International Network for the Study of Systemic Vasculitides. Hoffman GS, et al. Among authors: luqmani ra. Arthritis Rheum. 2002 May;46(5):1309-18. doi: 10.1002/art.10262. Arthritis Rheum. 2002. PMID: 12115238 Free article. Clinical Trial.

3

Outcome in small-vessel systemic vasculitis.

Luqmani RA, Flossmann O. Luqmani RA, et al. J Rheumatol. 2006 Jul;33(7):1224-7. J Rheumatol. 2006. PMID: 16821262 No abstract available.

4

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.

Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA. Hellmich B, et al. Among authors: luqmani ra. Ann Rheum Dis. 2007 May;66(5):605-17. doi: 10.1136/ard.2006.062711. Epub 2006 Dec 14. Ann Rheum Dis. 2007. PMID: 17170053 Free PMC article. Review.

5

The future of damage assessment in vasculitis.

Seo P, Luqmani RA, Flossmann O, Hellmich B, Herlyn K, Hoffman GS, Jayne D, Kallenberg CG, Langford CA, Mahr A, Matteson EL, Mukhtyar CB, Neogi T, Rutgers A, Specks U, Stone JH, Ytterberg SR, Merkel PA. Seo P, et al. Among authors: luqmani ra. J Rheumatol. 2007 Jun;34(6):1357-71. J Rheumatol. 2007. PMID: 17552062

6

Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.

Heijl C, Harper L, Flossmann O, Stücker I, Scott DG, Watts RA, Höglund P, Westman K, Mahr A; European Vasculitis Study Group (EUVAS). Heijl C, et al. Ann Rheum Dis. 2011 Aug;70(8):1415-21. doi: 10.1136/ard.2010.145250. Epub 2011 May 25. Ann Rheum Dis. 2011. PMID: 21616914 Review.

7

Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.

Direskeneli H, Aydin SZ, Kermani TA, Matteson EL, Boers M, Herlyn K, Luqmani RA, Neogi T, Seo P, Suppiah R, Tomasson G, Merkel PA. Direskeneli H, et al. Among authors: luqmani ra. J Rheumatol. 2011 Jul;38(7):1471-9. doi: 10.3899/jrheum.110275. J Rheumatol. 2011. PMID: 21724719 Free PMC article.

8

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.

Merkel PA, Aydin SZ, Boers M, Direskeneli H, Herlyn K, Seo P, Suppiah R, Tomasson G, Luqmani RA. Merkel PA, et al. Among authors: luqmani ra. J Rheumatol. 2011 Jul;38(7):1480-6. doi: 10.3899/jrheum.110276. J Rheumatol. 2011. PMID: 21724720 Free PMC article.

9

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.

Suppiah R, Hadden RD, Batra R, Arden NK, Collins MP, Guillevin L, Jayne DR, Luqmani RA; European Vasculitis Study Group. Suppiah R, et al. Among authors: luqmani ra. Rheumatology (Oxford). 2011 Dec;50(12):2214-22. doi: 10.1093/rheumatology/ker266. Epub 2011 Sep 2. Rheumatology (Oxford). 2011. PMID: 21890618

10

The characterisation and determinants of quality of life in ANCA associated vasculitis.

Basu N, McClean A, Harper L, Amft EN, Dhaun N, Luqmani RA, Little MA, Jayne DR, Flossmann O, McLaren J, Kumar V, Erwig LP, Reid DM, Jones GT, Macfarlane GJ. Basu N, et al. Among authors: luqmani ra. Ann Rheum Dis. 2014 Jan;73(1):207-11. doi: 10.1136/annrheumdis-2012-202750. Epub 2013 Jan 25. Ann Rheum Dis. 2014. PMID: 23355077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page